Skip to main content
. 2019 Nov 29;10(1):23–34. doi: 10.1016/j.jpha.2019.11.008

Table 4.

scFc analysis via RP-HRMS. Average experimental masses were determined based on triplicate analysis, as well as mass accuracies and relative abundancies. C-term lysine clipping was considered in the theoretical mass calculation unless indicated otherwise.

mAbs Modifications/Glycoforms Experimental mass (Da) Theoretical monoisotopic mass (Da) Mass difference (ppm) Relative abundance (%)
BEV Unglycosylated 23775.974 23775.930 1.9 1.4
A2G0F 25220.485 25220.463 0.8 84.9
A2G1F 25382.504 25382.516 0.5 10.3
A1G0F 25018.436 25017.380 2.3 1.9
A2G0 25074.482 25074.410 2.9 1.5
TRA A2G0 25074.431 25074.405 1.0 4.3
A2G0F 25220.513 25220.463 2.0 52.0
A2G1F 25382.581 25382.516 2.6 36.2
A1G0F 25017.445 25017.380 2.6 1.8
M5 24992.715 24992.350 14.6 1.6
A2G2F 25544.569 25544.569 0.0 4.1
INF M5 24960.391 24960.380 0.4 1.6
A1G0F 24985.423 24985.412 0.4 2.4
1x C-term lysine, M5 25088.477 25088.475 0.1 1.8
1x C-term lysine, A2G0F 25316.594 25316.586 0.3 38.6
1x C-term lysine, A2G1 25332.552 25332.581 1.1 1.4
1x C-term lysine, A2G0 25170.536 25170.528 0.3 3.0
A2G0F 25188.488 25188.487 0.0 30.2
A2G1F 25350.558 25350.544 0.6 10.9
1x C-term lysine, A2G1F 25478.629 25478.639 0.4 10.1
RIT A2G0F 25188.541 25188.491 2.0 44.2
A2G1F 25350.583 25350.544 1.5 48.3
A2G2F 25512.604 25512.597 0.3 7.5